gip and glp-1 receptor agonist The Emerging Role of Dual Agonists in Glycemic Management and Cardiovascular Risk Reduction Possible mechanisms of the interaction

GIPR, GIP receptor

The FDA also recommends examining hard clinical endpoints such hepatic decompensations, transplant free survival, and all-cause mortality, although these results are not necessarily needed prior to drug approval given the long length of follow up potentially required

All three are prescription drugs, requiring a professional medical evaluation, a prescription from an authorized physician, and dispensing by a pharmacist

Diabetes Care 39 , 17021710 (2016)

Tirzepatide produced weight loss at 72 weeks in the range of bariatric surgery, so a case can be made that this will be a cost-effective therapy

In severe cases, dialysis may be needed